Core Viewpoint - Lakeside Holding Limited reported a decline in revenues for the third quarter and first nine months of fiscal 2025, primarily due to challenges in the cross-border freight sector, but is optimistic about growth opportunities in the pharmaceutical distribution market following the acquisition of Hupan Pharmaceutical [2][4]. Financial Performance - Total revenues for Q3 FY2025 were $3.80 million, down from $4.46 million in Q3 FY2024, with contributions from cross-border freight solutions decreasing [5]. - Revenues from third-party cross-border freight solutions were $2.86 million, down from $3.82 million year-over-year, while pharmaceutical distribution generated $0.50 million, a new revenue stream [5][10]. - For the nine months ended March 31, 2025, total revenues were $11.48 million, compared to $13.53 million for the same period in FY2024 [10]. Cost and Profitability - The total cost of revenues for Q3 FY2025 was $3.09 million, leading to a gross profit of $0.72 million, down from $0.98 million in Q3 FY2024 [6]. - Operating expenses for Q3 FY2025 increased to $1.79 million from $0.94 million in the prior year, resulting in a loss from operations of $1.10 million [8]. - For the nine months ended March 31, 2025, the loss from operations was $4.40 million, compared to a loss of $0.21 million for the same period in FY2024 [12]. Strategic Initiatives - The company aims to expand its footprint in China's pharmaceutical distribution market while optimizing cross-border logistics services [3]. - Following the acquisition of Hupan Pharmaceutical, Lakeside is integrating operations to leverage synergies and explore new business opportunities [7]. - The company is focused on diversifying revenue streams and investing in high-growth areas despite challenges in the freight sector [4]. Recent Developments - Lakeside completed its IPO on July 1, 2024, raising approximately $6.75 million to support growth strategies [7]. - The acquisition of Hupan Pharmaceutical contributed $715,362 to revenues for the nine months ended March 31, 2025 [7]. - A convertible debt financing agreement for up to $4.5 million was announced on March 5, 2025, to provide additional working capital [7]. Geographic Revenue Distribution - For Q3 FY2025, revenues from Asia-based customers were $3.3 million, down from $3.8 million in the same period of the prior year, while U.S.-based customer revenues were $0.5 million [14]. - For the nine months ended March 31, 2025, revenues from Asia-based customers totaled $9.1 million, an increase from $8.1 million in the prior year, while U.S.-based customer revenues decreased to $2.4 million from $5.4 million [16].